Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.

Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Kim DS, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Worboys AM, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DA.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):199-208. doi: 10.1164/rccm.201810-1891OC.

2.

Genetics of cluster headache.

Gibson KF, Santos AD, Lund N, Jensen R, Stylianou IM.

Cephalalgia. 2019 Mar 27:333102418815503. doi: 10.1177/0333102418815503. [Epub ahead of print]

PMID:
30917683
3.

Assessing Patterns of Palliative Care Referral and Location of Death in Patients with Idiopathic Pulmonary Fibrosis: A Sixteen-Year Single-Center Retrospective Cohort Study.

Zou RH, Nouraie M, Chen X, Saul MI, Kaminski N, Gibson KF, Kass DJ, Lindell KO.

J Palliat Med. 2019 May;22(5):538-544. doi: 10.1089/jpm.2018.0400. Epub 2019 Jan 7.

PMID:
30615545
4.

A case series describing common radiographic and pathologic patterns of hard metal pneumoconiosis.

Chiarchiaro J, Tomsic LR, Strock S, Veraldi KL, Nouraie M, Sellares J, Lindell KO, Ortiz LA, Sciurba FC, Kucera RF, Yousem SA, Fuhrman CR, Kass DJ, Gibson KF.

Respir Med Case Rep. 2018 Aug 10;25:124-128. doi: 10.1016/j.rmcr.2018.08.006. eCollection 2018.

5.

Clinical Trials in Idiopathic Pulmonary Fibrosis in the "Posttreatment Era".

Gibson KF, Kass DJ.

JAMA. 2018 Jun 12;319(22):2275-2276. doi: 10.1001/jama.2018.6225. No abstract available.

PMID:
29800063
6.

S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension.

Tzouvelekis A, Herazo-Maya JD, Ryu C, Chu JH, Zhang Y, Gibson KF, Adonteng-Boateng PK, Li Q, Pan H, Cherry B, Ahmad F, Ford HJ, Herzog EL, Kaminski N, Fares WH.

Respirology. 2018 Aug;23(8):771-779. doi: 10.1111/resp.13302. Epub 2018 Apr 2.

7.

Randomised clinical trial of an early palliative care intervention (SUPPORT) for patients with idiopathic pulmonary fibrosis (IPF) and their caregivers: protocol and key design considerations.

Lindell KO, Nouraie M, Klesen MJ, Klein S, Gibson KF, Kass DJ, Rosenzweig MQ.

BMJ Open Respir Res. 2018 Feb 19;5(1):e000272. doi: 10.1136/bmjresp-2017-000272. eCollection 2018.

8.

Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study.

Herazo-Maya JD, Sun J, Molyneaux PL, Li Q, Villalba JA, Tzouvelekis A, Lynn H, Juan-Guardela BM, Risquez C, Osorio JC, Yan X, Michel G, Aurelien N, Lindell KO, Klesen MJ, Moffatt MF, Cookson WO, Zhang Y, Garcia JGN, Noth I, Prasse A, Bar-Joseph Z, Gibson KF, Zhao H, Herzog EL, Rosas IO, Maher TM, Kaminski N.

Lancet Respir Med. 2017 Nov;5(11):857-868. doi: 10.1016/S2213-2600(17)30349-1. Epub 2017 Sep 21.

9.

Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.

Kitsios GD, Rojas M, Kass DJ, Fitch A, Sembrat JC, Qin S, Veraldi KL, Gibson KF, Lindell K, Pilewski JM, Methe B, Li K, McDyer J, McVerry BJ, Morris A.

Thorax. 2018 May;73(5):481-484. doi: 10.1136/thoraxjnl-2017-210537. Epub 2017 Aug 11.

PMID:
28802277
10.

Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.

Aggarwal R, McBurney C, Schneider F, Yousem SA, Gibson KF, Lindell K, Fuhrman CR, Oddis CV.

Rheumatology (Oxford). 2017 Mar 1;56(3):384-389. doi: 10.1093/rheumatology/kew426.

PMID:
28082622
11.

Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial.

Raghu G, Brown KK, Collard HR, Cottin V, Gibson KF, Kaner RJ, Lederer DJ, Martinez FJ, Noble PW, Song JW, Wells AU, Whelan TP, Wuyts W, Moreau E, Patterson SD, Smith V, Bayly S, Chien JW, Gong Q, Zhang JJ, O'Riordan TG.

Lancet Respir Med. 2017 Jan;5(1):22-32. doi: 10.1016/S2213-2600(16)30421-0. Epub 2016 Dec 7.

PMID:
27939076
12.

The palliative care needs of patients with idiopathic pulmonary fibrosis: A qualitative study of patients and family caregivers.

Lindell KO, Kavalieratos D, Gibson KF, Tycon L, Rosenzweig M.

Heart Lung. 2017 Jan - Feb;46(1):24-29. doi: 10.1016/j.hrtlng.2016.10.002. Epub 2016 Nov 18.

13.

Referral to Palliative Care Infrequent in Patients with Idiopathic Pulmonary Fibrosis Admitted to an Intensive Care Unit.

Liang Z, Hoffman LA, Nouraie M, Kass DJ, Donahoe MP, Gibson KF, Saul MI, Lindell KO.

J Palliat Med. 2017 Feb;20(2):134-140. doi: 10.1089/jpm.2016.0258. Epub 2016 Oct 18.

PMID:
27754815
14.

Molecular chaperone Hsp27 regulates the Hippo tumor suppressor pathway in cancer.

Vahid S, Thaper D, Gibson KF, Bishop JL, Zoubeidi A.

Sci Rep. 2016 Aug 24;6:31842. doi: 10.1038/srep31842.

15.

New molecular targets for the treatment of sarcoidosis.

Chiarchiaro J, Chen BB, Gibson KF.

Curr Opin Pulm Med. 2016 Sep;22(5):515-21. doi: 10.1097/MCP.0000000000000304. Review.

16.

Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia.

Fingerlin TE, Zhang W, Yang IV, Ainsworth HC, Russell PH, Blumhagen RZ, Schwarz MI, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch DA, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Murphy E, Smith K, McKean D, Pedersen BS, Talbert J, Powers J, Markin CR, Beckman KB, Lathrop M, Freed B, Langefeld CD, Schwartz DA.

BMC Genet. 2016 Jun 7;17(1):74. doi: 10.1186/s12863-016-0377-2.

17.

A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.

Huang Y, Ma SF, Vij R, Oldham JM, Herazo-Maya J, Broderick SM, Strek ME, White SR, Hogarth DK, Sandbo NK, Lussier YA, Gibson KF, Kaminski N, Garcia JG, Noth I.

BMC Pulm Med. 2015 Nov 21;15:147. doi: 10.1186/s12890-015-0142-8.

18.

CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab.

Raghu G, Martinez FJ, Brown KK, Costabel U, Cottin V, Wells AU, Lancaster L, Gibson KF, Haddad T, Agarwal P, Mack M, Dasgupta B, Nnane IP, Flavin SK, Barnathan ES.

Eur Respir J. 2015 Dec;46(6):1740-50. doi: 10.1183/13993003.01558-2014. Epub 2015 Oct 22.

19.

Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.

Donahoe M, Valentine VG, Chien N, Gibson KF, Raval JS, Saul M, Xue J, Zhang Y, Duncan SR.

PLoS One. 2015 Jul 20;10(7):e0133684. doi: 10.1371/journal.pone.0133684. eCollection 2015. No abstract available.

20.

Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis Protocol.

Moller DR, Koth LL, Maier LA, Morris A, Drake W, Rossman M, Leader JK, Collman RG, Hamzeh N, Sweiss NJ, Zhang Y, O'Neal S, Senior RM, Becich M, Hochheiser HS, Kaminski N, Wisniewski SR, Gibson KF; GRADS Sarcoidosis Study Group.

Ann Am Thorac Soc. 2015 Oct;12(10):1561-71. doi: 10.1513/AnnalsATS.201503-172OT.

21.

Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis.

Donahoe M, Valentine VG, Chien N, Gibson KF, Raval JS, Saul M, Xue J, Zhang Y, Duncan SR.

PLoS One. 2015 Jun 17;10(6):e0127771. doi: 10.1371/journal.pone.0127771. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0133684.

22.

Lipopolysaccharide Primes the NALP3 Inflammasome by Inhibiting Its Ubiquitination and Degradation Mediated by the SCFFBXL2 E3 Ligase.

Han S, Lear TB, Jerome JA, Rajbhandari S, Snavely CA, Gulick DL, Gibson KF, Zou C, Chen BB, Mallampalli RK.

J Biol Chem. 2015 Jul 17;290(29):18124-33. doi: 10.1074/jbc.M115.645549. Epub 2015 Jun 2.

23.

Fullerene oxidation and clustering in solution induced by light.

Dattani R, Gibson KF, Few S, Borg AJ, DiMaggio PA, Nelson J, Kazarian SG, Cabral JT.

J Colloid Interface Sci. 2015 May 15;446:24-30. doi: 10.1016/j.jcis.2015.01.005. Epub 2015 Jan 22.

24.

Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis.

Wilkes DS, Chew T, Flaherty KR, Frye S, Gibson KF, Kaminski N, Klemsz MJ, Lange W, Noth I, Rothhaar K.

Eur Respir J. 2015 May;45(5):1393-402. doi: 10.1183/09031936.00105314. Epub 2015 Jan 22.

25.

Discovery of catalytic phages by biocatalytic self-assembly.

Maeda Y, Javid N, Duncan K, Birchall L, Gibson KF, Cannon D, Kanetsuki Y, Knapp C, Tuttle T, Ulijn RV, Matsui H.

J Am Chem Soc. 2014 Nov 12;136(45):15893-6. doi: 10.1021/ja509393p. Epub 2014 Oct 29.

26.

Palliative care and location of death in decedents with idiopathic pulmonary fibrosis.

Lindell KO, Liang Z, Hoffman LA, Rosenzweig MQ, Saul MI, Pilewski JM, Gibson KF, Kaminski N.

Chest. 2015 Feb;147(2):423-429. doi: 10.1378/chest.14-1127.

27.

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis.

Judson MA, Baughman RP, Costabel U, Drent M, Gibson KF, Raghu G, Shigemitsu H, Barney JB, Culver DA, Hamzeh NY, Wijsenbeek MS, Albera C, Huizar I, Agarwal P, Brodmerkel C, Watt R, Barnathan ES.

Eur Respir J. 2014 Nov;44(5):1296-307. doi: 10.1183/09031936.00000914. Epub 2014 Jul 17.

28.

A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis.

Bauer Y, Tedrow J, de Bernard S, Birker-Robaczewska M, Gibson KF, Guardela BJ, Hess P, Klenk A, Lindell KO, Poirey S, Renault B, Rey M, Weber E, Nayler O, Kaminski N.

Am J Respir Cell Mol Biol. 2015 Feb;52(2):217-31. doi: 10.1165/rcmb.2013-0310OC.

29.

Pulmonary pathologic manifestations of anti-glycyl-tRNA synthetase (anti-EJ)-related inflammatory myopathy.

Schneider F, Yousem SA, Bi D, Gibson KF, Oddis CV, Aggarwal R.

J Clin Pathol. 2014 Aug;67(8):678-83. doi: 10.1136/jclinpath-2014-202367. Epub 2014 Jun 2.

PMID:
24891607
30.

C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.

Vuga LJ, Tedrow JR, Pandit KV, Tan J, Kass DJ, Xue J, Chandra D, Leader JK, Gibson KF, Kaminski N, Sciurba FC, Duncan SR.

Am J Respir Crit Care Med. 2014 Apr 15;189(8):966-74. doi: 10.1164/rccm.201309-1592OC.

31.

Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.

Vuga LJ, Milosevic J, Pandit K, Ben-Yehudah A, Chu Y, Richards T, Sciurba J, Myerburg M, Zhang Y, Parwani AV, Gibson KF, Kaminski N.

PLoS One. 2013 Dec 20;8(12):e83120. doi: 10.1371/journal.pone.0083120. eCollection 2013.

32.

Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial.

Baughman RP, Culver DA, Cordova FC, Padilla M, Gibson KF, Lower EE, Engel PJ.

Chest. 2014 Apr;145(4):810-817. doi: 10.1378/chest.13-1766.

PMID:
24177203
33.

Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression.

Chien JW, Richards TJ, Gibson KF, Zhang Y, Lindell KO, Shao L, Lyman SK, Adamkewicz JI, Smith V, Kaminski N, O'Riordan T.

Eur Respir J. 2014 May;43(5):1430-8. doi: 10.1183/09031936.00141013. Epub 2013 Oct 31.

34.

Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis.

Herazo-Maya JD, Noth I, Duncan SR, Kim S, Ma SF, Tseng GC, Feingold E, Juan-Guardela BM, Richards TJ, Lussier Y, Huang Y, Vij R, Lindell KO, Xue J, Gibson KF, Shapiro SD, Garcia JG, Kaminski N.

Sci Transl Med. 2013 Oct 2;5(205):205ra136. doi: 10.1126/scitranslmed.3005964.

35.

Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients.

Xue J, Kass DJ, Bon J, Vuga L, Tan J, Csizmadia E, Otterbein L, Soejima M, Levesque MC, Gibson KF, Kaminski N, Pilewski JM, Donahoe M, Sciurba FC, Duncan SR.

J Immunol. 2013 Sep 1;191(5):2089-95. doi: 10.4049/jimmunol.1203476. Epub 2013 Jul 19.

36.

Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.

Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JG, Richards TJ, Silveira LJ, Lindell KO, Steele MP, Loyd JE, Gibson KF, Seibold MA, Brown KK, Talbert JL, Markin C, Kossen K, Seiwert SD, Murphy E, Noth I, Schwarz MI, Kaminski N, Schwartz DA.

JAMA. 2013 Jun 5;309(21):2232-9. doi: 10.1001/jama.2013.5827.

37.

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.

Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch D, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Cogan JD, Mason WR, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Smith K, McKean D, Pedersen BS, Talbert J, Kidd RN, Markin CR, Beckman KB, Lathrop M, Schwarz MI, Schwartz DA.

Nat Genet. 2013 Jun;45(6):613-20. doi: 10.1038/ng.2609. Epub 2013 Apr 14. Erratum in: Nat Genet. 2013 Nov;45(11):1409.

38.

Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.

Kahloon RA, Xue J, Bhargava A, Csizmadia E, Otterbein L, Kass DJ, Bon J, Soejima M, Levesque MC, Lindell KO, Gibson KF, Kaminski N, Banga G, Oddis CV, Pilewski JM, Sciurba FC, Donahoe M, Zhang Y, Duncan SR.

Am J Respir Crit Care Med. 2013 Apr 1;187(7):768-75. doi: 10.1164/rccm.201203-0506OC.

39.

Profibrotic role of miR-154 in pulmonary fibrosis.

Milosevic J, Pandit K, Magister M, Rabinovich E, Ellwanger DC, Yu G, Vuga LJ, Weksler B, Benos PV, Gibson KF, McMillan M, Kahn M, Kaminski N.

Am J Respir Cell Mol Biol. 2012 Dec;47(6):879-87. doi: 10.1165/rcmb.2011-0377OC. Epub 2012 Oct 4.

40.

Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humans.

Yu G, Kovkarova-Naumovski E, Jara P, Parwani A, Kass D, Ruiz V, Lopez-Otín C, Rosas IO, Gibson KF, Cabrera S, Ramírez R, Yousem SA, Richards TJ, Chensny LJ, Selman M, Kaminski N, Pardo A.

Am J Respir Crit Care Med. 2012 Oct 15;186(8):752-62. doi: 10.1164/rccm.201202-0302OC. Epub 2012 Aug 2.

41.

Angle-dependent resonance of localized and propagating surface plasmons in microhole arrays for enhanced biosensing.

Live LS, Dhawan A, Gibson KF, Poirier-Richard HP, Graham D, Canva M, Vo-Dinh T, Masson JF.

Anal Bioanal Chem. 2012 Dec;404(10):2859-68. doi: 10.1007/s00216-012-6195-0. Epub 2012 Jul 4.

PMID:
22760504
42.

Plasma proteins for risk prediction in idiopathic pulmonary fibrosis.

Richards TJ, Kaminski N, Gibson KF.

Am J Respir Crit Care Med. 2012 Jun 15;185(12):1329-30. No abstract available.

43.

Global methylation patterns in idiopathic pulmonary fibrosis.

Rabinovich EI, Kapetanaki MG, Steinfeld I, Gibson KF, Pandit KV, Yu G, Yakhini Z, Kaminski N.

PLoS One. 2012;7(4):e33770. doi: 10.1371/journal.pone.0033770. Epub 2012 Apr 10.

44.

Assessing the Location of Surface Plasmons Over Nanotriangle and Nanohole Arrays of Different Size and Periodicity.

Correia-Ledo D, Gibson KF, Dhawan A, Couture M, Vo-Dinh T, Graham D, Masson JF.

J Phys Chem C Nanomater Interfaces. 2012 Mar 29;116(12):6884-6892.

45.

Allele-specific transactivation of matrix metalloproteinase 7 by FOXA2 and correlation with plasma levels in idiopathic pulmonary fibrosis.

Richards TJ, Park C, Chen Y, Gibson KF, Peter Di Y, Pardo A, Watkins SC, Choi AM, Selman M, Pilewski J, Kaminski N, Zhang Y.

Am J Physiol Lung Cell Mol Physiol. 2012 Apr 15;302(8):L746-54. doi: 10.1152/ajplung.00319.2011. Epub 2012 Jan 20.

46.

Where next for gene expression profiling? So much promise.

Noth I, Gibson KF, Drake WP.

Am J Respir Crit Care Med. 2011 Nov 15;184(10):1102-3. doi: 10.1164/rccm.201109-1612ED. No abstract available.

PMID:
22086986
47.

Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.

Richards TJ, Kaminski N, Baribaud F, Flavin S, Brodmerkel C, Horowitz D, Li K, Choi J, Vuga LJ, Lindell KO, Klesen M, Zhang Y, Gibson KF.

Am J Respir Crit Care Med. 2012 Jan 1;185(1):67-76. doi: 10.1164/rccm.201101-0058OC. Erratum in: Am J Respir Crit Care Med. 2012 Feb 15;185(4):464.

48.

The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis.

Xue J, Gochuico BR, Alawad AS, Feghali-Bostwick CA, Noth I, Nathan SD, Rosen GD, Rosas IO, Dacic S, Ocak I, Fuhrman CR, Cuenco KT, Smith MA, Jacobs SS, Zeevi A, Morel PA, Pilewski JM, Valentine VG, Gibson KF, Kaminski N, Sciurba FC, Zhang Y, Duncan SR.

PLoS One. 2011 Feb 23;6(2):e14715. doi: 10.1371/journal.pone.0014715.

49.

Correlated AFM and SERS imaging of the transition from nanotriangle to nanohole arrays.

Gibson KF, Correia-Ledo D, Couture M, Graham D, Masson JF.

Chem Commun (Camb). 2011 Mar 28;47(12):3404-6. doi: 10.1039/c0cc05287f. Epub 2011 Feb 18.

PMID:
21336354
50.

Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners.

Lindell KO, Olshansky E, Song MK, Zullo TG, Gibson KF, Kaminski N, Hoffman LA.

Heart Lung. 2010 Jul-Aug;39(4):304-13. doi: 10.1016/j.hrtlng.2009.08.005. Epub 2009 Nov 20.

Supplemental Content

Loading ...
Support Center